Advertisement

PharmacoEconomics & Outcomes News

, Volume 821, Issue 1, pp 11–11 | Cite as

Considerable economic burden of MenB in Germany

Clinical study

Reference

  1. Scholz S, et al. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine : 18 Jan 2019. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2019.01.013Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations